این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Middle East Journal of Cancer، جلد ۱۶، شماره ۲، صفحات ۱۰۹-۱۱۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی MLH1 Methylation-Based Testing in Peripheral Blood Mononuclear Cells is a Promising Biomarker for Colorectal Cancer Diagnosis and Prognosis
چکیده انگلیسی مقاله Background: Recent evidence has shown that peripheral blood mononuclear cells (PBMCs) can reflect the epigenetic profile of tissues they interact with, such as malignant cells. The hypermethylation of MLH1 promoter is a well-defined epigenetic alteration in the development of colorectal cancer (CRC). This is the first study aimed to assess the diagnostic and prognostic values of the methylation level of MLH1 promoter in PBMCs of patients with CRC.
Method: In this case-control study, the methylation level at the promoter region of MLH1 was quantitatively analyzed in 60 CRC patients and 60 non-cancerous study participants via methylation-quantification of endonuclease-resistant DNA (MethyQESD). The receiver operating characteristic (ROC) curves were constructed and the areas under the curve were calculated to determine the diagnostic significance of MLH1 gene methylation.
Results: Our data showed a significant increase in methylation of MLH1 in CRC patients compared with healthy participants (P < 0.001). Moreover, the specificity of MLH1 hypermethylation for precise diagnosis of healthy participants was 75% and its sensitivity for CRC diagnosis was 76.7%. With ROC curve analyses, we found that MLH1 promoter methylation holds a likelihood of 76.8% for distinguishing between CRC patients and healthy individuals (P > 0.001). Besides, MLH1 methylation levels was significantly increased in CRC patients with higher tumor stages, suggesting a probable correlation between an increased percentage of methylation and tumor progression (P < 0.001). However, no statistically significant association was found between methylation status of MLH1 and microsatellite instability (P > 0.05).
Conclusion: Our results propose that MLH1 methylation status in PBMCs can be used as a promising diagnostic and prognostic biomarker and reliable factor for CRC screening.
کلیدواژه‌های انگلیسی مقاله MLH1,Colorectal neoplasms,Biomarkers,diagnosis
نویسندگان مقاله Farzaneh Yousefisadr |
Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Meysam Mosallaei |
Medical Biotechnology Research Center, Aja University of Medical Sciences, Tehran, Iran

Shahryar Sadeghi |
Surgical Department, Imam Reza Hospital, Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran

Hassan Mehrad-Majd |
Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Ali Beheshti Namdar |
Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

نشانی اینترنتی https://mejc.sums.ac.ir/article_50318_686b85f73f169877d7f4515fb555a3a8.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات